Helius Medical appoints Paul Buckman to Board of Directors effective Sept 10, 2021

Solana Co

Paul Buckman appointed as independent director; board size increased from five to six.
He will serve as Chair of Audit Committee, member of Compensation and Nominating & Governance Committees.
Buckman currently President North America of LivaNova PLC; 30+ years in medical devices.
Board determined he meets Nasdaq independence criteria; will enter standard indemnification agreement.
Prior leadership roles include CEO of Conventus Orthopaedics, SentreHeart, Pathway Medical, and ev3.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Paul Buckman

Director

HSDT · Solana Co

Effective: 2021-09-10
Filed: September 14, 2021, 7:59 PM ET

approved an increase in the size of the Board from five to six directors and the appointment of Paul Buckman to fill the vacancy created by such increase, which appointment became effective on September 10, 2021 upon Mr. Buckman’s acceptance.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Buckman was appointed as Director at Solana Co.

Action: appointed
Role: Director

Exact text from the filing

approved an increase in the size of the Board from five to six directors and the appointment of Paul Buckman to fill the vacancy created by such increase, which appointment became effective on September 10, 2021 upon Mr. Buckman’s acceptance.

View on SEC.gov

Solana Co filing history →

Source: SEC EDGAR

accession 0001564590-21-047796

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.